Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

Clinical trial NCT03298061 · COMPLETED

Trial details

NCT number: NCT03298061
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Churg-Strauss Syndrome Eosinophilic Granulomatosis With Polyangiitis

Start date: 2015-04-14
Primary completion: 2023-02-16
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.